Paper837372
Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors.
Meltzer MS and 2 others. Cancer Res, 1977. Cited by 63 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. Papers, record 837372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/837372
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemotaxis | Major topic |
| Lymphocytes | Major topic |
| Macrophages | Major topic |
| Sarcoma, Experimental | Major topic |
| Animals | |
| Ascitic Fluid | |
| Cell Division | |
| Cells, Cultured | |
| Chemotaxis, Leukocyte | |
| Culture Media | |
| Male | |
| Mice | |
| Mice, Inbred C3H |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,286,437 | CCL2 in the Tumor Microenvironment. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/34286437 | PubMed |
| 29,375,123 | The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? | Cell Mol Immunol | 2018 | https://conductscience.org/library/papers/29375123 | PubMed |
| 6,977,544 | Lymphoid cells in lymph nodes and peripheral blood of patients with squamous cell carcinoma of the head and neck. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/6977544 | PubMed |
| 6,970,165 | The induction of human peripheral blood lymphoid colonies by conditioned media from human tumour cell lines. | Immunology | 1980 | https://conductscience.org/library/papers/6970165 | PubMed |
| 6,764,378 | Macrophages and neoplasms: new insights and their implication in tumor immunobiology. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/6764378 | PubMed |
| 6,466,553 | Effects of soluble mediators generated during growth of the Landschütz ascites carcinoma on the chemotaxis of normal and Corynebacterium parvum-stimulated peritoneal leucocytes. | Br J Exp Pathol | 1984 | https://conductscience.org/library/papers/6466553 | PubMed |
| 3,907,821 | Macrophage infiltration and tumor progression. | Cancer Metastasis Rev | 1985 | https://conductscience.org/library/papers/3907821 | PubMed |
| 2,926,329 | Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. | J Exp Med | 1989 | https://conductscience.org/library/papers/2926329 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/837372
GET https://conductscience.org/api/papers/v1/837372/authors